AU2215300A - Methods and compositions for inhibiting neoplastic cell growth - Google Patents

Methods and compositions for inhibiting neoplastic cell growth

Info

Publication number: AU2215300A
Authority: AU; Australia
Prior art keywords: compositions; methods; cell growth; neoplastic cell; inhibiting neoplastic
Prior art date: 1999-06-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU22153/00A

Inventor

Avi J. Ashkenazi

Audrey Goddard

Austin L. Gurney

Kenneth Hillan

Mary Napier

William I. Wood

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Genentech Inc

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-02

Filing date

1999-12-20

Publication date

2000-12-28

1999-06-02 Priority claimed from PCT/US1999/012252 external-priority patent/WO1999063088A2/en

1999-09-15 Priority claimed from PCT/US1999/021090 external-priority patent/WO2000015796A2/en

1999-09-15 Priority claimed from PCT/US1999/021547 external-priority patent/WO2000015797A2/en

1999-11-30 Priority claimed from PCT/US1999/028313 external-priority patent/WO2000032221A2/en

1999-12-20 Application filed by Genentech Inc filed Critical Genentech Inc

2000-12-28 Publication of AU2215300A publication Critical patent/AU2215300A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AU22153/00A 1999-06-02 1999-12-20 Methods and compositions for inhibiting neoplastic cell growth Abandoned AU2215300A (en)

Applications Claiming Priority (13)

Application Number	Priority Date	Filing Date	Title
WOUS9912252		1999-06-02
PCT/US1999/012252 WO1999063088A2 (en)	1998-06-02	1999-06-02	Membrane-bound proteins and nucleic acids encoding the same
US14103799P	1999-06-23	1999-06-23
US60141037		1999-06-23
US14304899P	1999-07-07	1999-07-07
US60143048		1999-07-07
PCT/US1999/021090 WO2000015796A2 (en)	1998-09-16	1999-09-15	Secreted and transmembrane polypeptides and nucleic acids encoding the same
WOUS9921547		1999-09-15
WOUS9921090		1999-09-15
PCT/US1999/021547 WO2000015797A2 (en)	1998-09-17	1999-09-15	Compositions and methods for the treatment of immune related diseases
PCT/US1999/028313 WO2000032221A2 (en)	1998-12-01	1999-11-30	Promotion or inhibition of angiogenesis and cardiovascularization
WOUS9928313		1999-11-30
PCT/US1999/030911 WO2000075316A1 (en)	1999-06-02	1999-12-20	Methods and compositions for inhibiting neoplastic cell growth

Publications (1)

Publication Number	Publication Date
AU2215300A true AU2215300A (en)	2000-12-28

Family

ID=56289981

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU22153/00A Abandoned AU2215300A (en)	1999-06-02	1999-12-20	Methods and compositions for inhibiting neoplastic cell growth

Country Status (2)

Country	Link
AU (1)	AU2215300A (en)
WO (1)	WO2000075316A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7285267B2 (en)	1997-01-14	2007-10-23	Human Genome Sciences, Inc.	Tumor necrosis factor receptors 6α & 6β
DE10254601A1 (en)	2002-11-22	2004-06-03	Ganymed Pharmaceuticals Ag	Gene products differentially expressed in tumors and their use
DE102004024617A1 (en)	2004-05-18	2005-12-29	Ganymed Pharmaceuticals Ag	Differentially expressed in tumors gene products and their use
EP1790664A1 (en)	2005-11-24	2007-05-30	Ganymed Pharmaceuticals AG	Monoclonal antibodies against claudin-18 for treatment of cancer
WO2013167153A1 (en)	2012-05-09	2013-11-14	Ganymed Pharmaceuticals Ag	Antibodies useful in cancer diagnosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ226799A (en) *	1987-11-06	1991-08-27	Oncogen	Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
US5814307A (en) *	1989-04-10	1998-09-29	Bristol-Myers Squibb Company	Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6
US5416192A (en) *	1990-04-03	1995-05-16	Bristol-Myers Squibb Company	Epithelins: novel cysteine-rich growth modulating proteins
US5885800A (en) *	1997-02-04	1999-03-23	Smithkline Beecham Corporation	DNA encoding tumor necrosis related receptor, TR4
WO1999004001A1 (en) *	1997-07-21	1999-01-28	Zymogenetics, Inc.	Tumor necrosis factor receptor ztnfr-5
AU762959B2 (en) *	1997-09-18	2003-07-10	Genentech Inc.	DcR3 polypeptide, A TNFR homolog

1999
- 1999-12-20 AU AU22153/00A patent/AU2215300A/en not_active Abandoned
- 1999-12-20 WO PCT/US1999/030911 patent/WO2000075316A1/en active Search and Examination

Also Published As

Publication number	Publication date
WO2000075316A1 (en)	2000-12-14

Publication	Publication Date	Title
AUPQ419099A0 (en)	1999-12-16	Novel compositions and methods
AU3652499A (en)	1999-12-20	Iol for inhibiting cell growth and reducing glare
IL140686A0 (en)	2002-02-10	Compositions and methods for inhibiting fungal growth
AU7989400A (en)	2001-05-10	Compounds and methods
AU3215500A (en)	2000-08-07	Compounds and methods
AU5170900A (en)	2000-12-18	Cell proliferation inhibitors
AU5994900A (en)	2001-01-30	Compounds for inhibiting diseases and preparing cells for transplantation
AU5991699A (en)	2000-04-10	Quinolizinones as integrin inhibitors
AU3246100A (en)	2000-12-28	Methods and compositions for inhibiting neoplastic cell growth
AU2001233502A1 (en)	2001-11-08	Pancreatic islet cell growth factors
AU2832399A (en)	1999-08-30	B cell inhibitors
AU4859399A (en)	2000-01-24	Compositions and methods for treating papillomavirus-infected cells
AU3235100A (en)	2000-09-04	Prothease inhibitors
AU6094200A (en)	2001-03-19	Nor gene compositions and methods for use thereof
AU2215300A (en)	2000-12-28	Methods and compositions for inhibiting neoplastic cell growth
AU2399300A (en)	2000-09-28	Methods and compositions for inhibiting neoplastic cell growth
AU4849199A (en)	2000-01-24	Fungal growth inhibitors
AU6859500A (en)	2001-04-10	Plant gene
AU1389801A (en)	2001-05-08	Modification of plants
AU1749800A (en)	2000-10-04	Methods and compositions for inhibiting neoplastic cell growth
AU6006800A (en)	2001-02-05	Treating cells
AU5640200A (en)	2001-01-31	Gene affecting male fertility in plants
AU4328700A (en)	2000-11-02	Pseudomycin antifungal compositions and methods for their use
AU5591100A (en)	2000-12-18	Methods and compositions for inhibiting neoplastic cell growth
IL147148A0 (en)	2002-08-14	Epithelial cell growth inhibitors

Legal Events

Date	Code	Title	Description
2002-04-11	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase